Filed 1mo ago· Apr 13, 2026
18 days to disclose
Thomas H. Kean Jr.
RHouseNew Jersey-07
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+1.9% vs S&P 500
Trade dateMar 26, 2026
⚑ Pharmaceutical
Recent filings
Every politician trade, as it’s filed.
Stock trades that members of the U.S. House and Senate disclose, by law, after they buy or sell. Pulled straight from the official government websites — typically posted within hours of being filed.
Showing 1–100 of 133
Filed 1mo ago· Apr 7, 2026
19 days to disclose
Richard McCormick
RHouseGeorgia-07
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+1.3% vs S&P 500
Trade dateMar 19, 2026
⚑ Pharmaceutical
Filed 1mo ago· Apr 7, 2026
19 days to discloseRichard McCormick
RHouseGeorgia-07
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+1.3% vs S&P 500
Trade dateMar 19, 2026
⚑ Pharmaceutical
Filed 1mo ago· Apr 6, 2026
27 days to disclose
Lloyd Doggett
DHouseTexas-37
↑bought
Johnson & Johnson
JNJ
$1K-$15K
−2.1% vs S&P 500
Trade dateMar 10, 2026
⚑ Pharmaceutical
Filed 3mo ago· Feb 19, 2026
27 days to discloseThomas H. Kean Jr.
RHouseNew Jersey-07
↓sold
Johnson & Johnson
JNJ
$15K-$50K
−5.7% vs S&P 500
Trade dateJan 23, 2026
⚑ Pharmaceutical
Filed 4mo ago· Jan 15, 2026
28 days to disclose
Julie Johnson
DHouseTexas-32
↓sold
Johnson & Johnson
JNJ
$1K-$15K
−3.5% vs S&P 500
Trade dateDec 18, 2025
Filed 5mo ago· Jan 2, 2026
24 days to discloseLloyd Doggett
DHouseTexas-37
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+16.6% vs S&P 500
Trade dateDec 9, 2025
⚑ Pharmaceutical
Filed 5mo ago· Dec 19, 2025
29 days to discloseThomas H. Kean Jr.
RHouseNew Jersey-07
↓sold
Johnson & Johnson
JNJ
$15K-$50K
−1.9% vs S&P 500
Trade dateNov 20, 2025
⚑ Pharmaceutical
Filed 5mo ago· Dec 11, 2025
28 days to discloseJulie Johnson
DHouseTexas-32
↓sold
Johnson & Johnson
JNJ
$1K-$15K
−2.8% vs S&P 500
Trade dateNov 13, 2025
Filed 5mo ago· Dec 9, 2025
34 days to discloseRichard McCormick
RHouseGeorgia-07
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+22.4% vs S&P 500
Trade dateNov 5, 2025
⚑ Pharmaceutical
Filed 6mo ago· Nov 22, 2025
43 days to disclose
Jared Moskowitz
DHouseFlorida-23
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+4.5% vs S&P 500
Trade dateOct 10, 2025
Filed 6mo ago· Nov 22, 2025
43 days to discloseJared Moskowitz
DHouseFlorida-23
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+4.5% vs S&P 500
Trade dateOct 10, 2025
Filed 6mo ago· Nov 21, 2025
21 days to disclose
Lisa C. McClain
RHouseMichigan-09
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+3.0% vs S&P 500
Trade dateOct 31, 2025
⚑ Pharmaceutical
Filed 6mo ago· Nov 21, 2025
22 days to discloseLisa C. McClain
RHouseMichigan-09
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+2.9% vs S&P 500
Trade dateOct 30, 2025
⚑ Pharmaceutical
Filed 6mo ago· Nov 21, 2025
22 days to discloseLisa C. McClain
RHouseMichigan-09
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+19.4% vs S&P 500
Trade dateOct 30, 2025
⚑ Pharmaceutical
Filed 7mo ago· Oct 10, 2025
17 days to disclose
Val T. Hoyle
DHouseOregon-04
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+8.4% vs S&P 500
Trade dateSep 23, 2025
Filed 8mo ago· Oct 5, 2025
200 days to disclose · 155 past 45-day window
Sheri Biggs
RHouseSouth Carolina-03
↓sold
Johnson & Johnson
JNJ
$15K-$50K
+1.1% vs S&P 500
Trade dateMar 19, 2025
⚑ Pharmaceutical
Filed 8mo ago· Sep 17, 2025
917 days to disclose · 872 past 45-day windowRichard McCormick
RHouseGeorgia-07
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+32.3% vs S&P 500
Trade dateMar 15, 2023
⚑ Pharmaceutical
Filed 8mo ago· Sep 12, 2025
39 days to discloseLisa C. McClain
RHouseMichigan-09
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+23.6% vs S&P 500
Trade dateAug 4, 2025
⚑ Pharmaceutical
Filed 8mo ago· Sep 12, 2025
318 days to disclose · 273 past 45-day windowVal T. Hoyle
DHouseOregon-04
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+47.5% vs S&P 500
Trade dateOct 29, 2024
Filed 8mo ago· Sep 11, 2025
23 days to disclose
Kelly Morrison
DHouseMinnesota-03
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+8.6% vs S&P 500
Trade dateAug 19, 2025
⚑ Pharmaceutical
Filed 8mo ago· Sep 11, 2025
28 days to discloseJulie Johnson
DHouseTexas-32
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+10.9% vs S&P 500
Trade dateAug 14, 2025
Filed 9mo ago· Aug 20, 2025
20 days to discloseThomas H. Kean Jr.
RHouseNew Jersey-07
↓sold
Johnson & Johnson
JNJ
$15K-$50K
+13.9% vs S&P 500
Trade dateJul 31, 2025
⚑ Pharmaceutical
Filed 9mo ago· Aug 20, 2025
328 days to disclose · 283 past 45-day window
Ritchie Torres
DHouseNew York-15
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+16.2% vs S&P 500
Trade dateSep 26, 2024
Filed 9mo ago· Aug 13, 2025
50 days to disclose · 5 past 45-day windowLisa C. McClain
RHouseMichigan-09
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+11.0% vs S&P 500
Trade dateJun 24, 2025
⚑ Pharmaceutical
Filed 9mo ago· Aug 13, 2025
57 days to disclose · 12 past 45-day windowLisa C. McClain
RHouseMichigan-09
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+40.5% vs S&P 500
Trade dateJun 17, 2025
⚑ Pharmaceutical
Filed 10mo ago· Jul 14, 2025
28 days to disclose
Scott Franklin
RHouseFlorida-18
↓sold
Johnson & Johnson
JNJ
$15K-$50K
+9.4% vs S&P 500
Trade dateJun 16, 2025
Filed 11mo ago· Jul 7, 2025
27 days to discloseLloyd Doggett
DHouseTexas-37
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+38.4% vs S&P 500
Trade dateJun 10, 2025
⚑ Pharmaceutical
Filed 11mo ago· Jul 3, 2025
330 days to disclose · 285 past 45-day windowScott Franklin
RHouseFlorida-18
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+43.9% vs S&P 500
Trade dateAug 7, 2024
Filed 11mo ago· Jun 22, 2025
41 days to disclose
Jefferson Shreve
RHouseIndiana-06
↓sold
Johnson & Johnson
JNJ
$50K-$100K
+9.2% vs S&P 500
Trade dateMay 12, 2025
Filed 11mo ago· Jun 21, 2025
9 days to disclose
Pete Sessions
RHouseTexas-17
↓sold
Johnson & Johnson
JNJ
$15K-$50K
+8.6% vs S&P 500
Trade dateJun 12, 2025
Filed 12mo ago· Jun 6, 2025
7 days to disclose
Gilbert Ray Cisneros Jr.
DHouseCalifornia-31
↑bought
Johnson & Johnson
JNJ
$15K-$50K
+37.1% vs S&P 500
Trade dateMay 30, 2025
Filed 1.1y ago· May 14, 2025
35 days to disclose
Josh Gottheimer
DHouseNew Jersey-05
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+7.0% vs S&P 500
Trade dateApr 9, 2025
Filed 1.1y ago· May 14, 2025
43 days to discloseJulie Johnson
DHouseTexas-32
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+3.6% vs S&P 500
Trade dateApr 1, 2025
Filed 1.1y ago· May 12, 2025
21 days to disclose
Bruce Westerman
RHouseArkansas-04
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+12.0% vs S&P 500
Trade dateApr 21, 2025
Filed 1.1y ago· May 6, 2025
1 day to disclose
Marjorie Taylor Greene
RHouseGeorgia-14
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+41.7% vs S&P 500
Trade dateMay 5, 2025
Filed 1.1y ago· May 6, 2025
7 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+6.6% vs S&P 500
Trade dateApr 29, 2025
Filed 1.1y ago· Apr 28, 2025
20 days to disclose
Robert P. Bresnahan Jr.
RHousePennsylvania-08
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+11.7% vs S&P 500
Trade dateApr 8, 2025
⚑ Pharmaceutical
Filed 1.1y ago· Apr 23, 2025
30 days to disclose
George Whitesides
DHouseCalifornia-27
↓sold
Johnson & Johnson
JNJ
$100K-$250K
+2.2% vs S&P 500
Trade dateMar 24, 2025
Filed 1.1y ago· Apr 16, 2025
44 days to discloseBruce Westerman
RHouseArkansas-04
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+39.0% vs S&P 500
Trade dateMar 3, 2025
Filed 1.1y ago· Apr 11, 2025
37 days to discloseJefferson Shreve
RHouseIndiana-06
↑bought
Johnson & Johnson
JNJ
$15K-$50K
+40.9% vs S&P 500
Trade dateMar 5, 2025
Filed 1.1y ago· Apr 10, 2025
34 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Johnson & Johnson
JNJ
$1K-$15K
−0.5% vs S&P 500
Trade dateMar 7, 2025
Filed 1.2y ago· Apr 7, 2025
7 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↑bought
Johnson & Johnson
JNJ
$15K-$50K
+37.8% vs S&P 500
Trade dateMar 31, 2025
Filed 1.2y ago· Apr 7, 2025
34 days to discloseLloyd Doggett
DHouseTexas-37
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+39.6% vs S&P 500
Trade dateMar 4, 2025
⚑ Pharmaceutical
Filed 1.2y ago· Mar 9, 2025
13 days to discloseJefferson Shreve
RHouseIndiana-06
↑bought
Johnson & Johnson
JNJ
$15K-$50K
+40.7% vs S&P 500
Trade dateFeb 24, 2025
Filed 1.3y ago· Feb 11, 2025
18 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+2.9% vs S&P 500
Trade dateJan 24, 2025
Filed 1.3y ago· Feb 10, 2025
17 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+54.6% vs S&P 500
Trade dateJan 24, 2025
Filed 1.3y ago· Feb 10, 2025
20 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+51.9% vs S&P 500
Trade dateJan 21, 2025
Filed 1.3y ago· Feb 10, 2025
25 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+51.3% vs S&P 500
Trade dateJan 16, 2025
Filed 1.3y ago· Jan 27, 2025
19 days to discloseMarjorie Taylor Greene
RHouseGeorgia-14
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+56.8% vs S&P 500
Trade dateJan 8, 2025
Filed 1.3y ago· Jan 27, 2025
19 days to discloseMarjorie Taylor Greene
RHouseGeorgia-14
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+56.8% vs S&P 500
Trade dateJan 8, 2025
Filed 1.3y ago· Jan 27, 2025
19 days to discloseMarjorie Taylor Greene
RHouseGeorgia-14
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+56.8% vs S&P 500
Trade dateJan 8, 2025
Filed 1.4y ago· Jan 15, 2025
15 days to disclose
Kevin Hern
RHouseOklahoma-01
↓sold
Johnson & Johnson
JNJ
$100K-$250K
+8.0% vs S&P 500
Trade dateDec 31, 2024
⚑ Pharmaceutical
Filed 1.4y ago· Jan 14, 2025
33 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+52.9% vs S&P 500
Trade dateDec 12, 2024
Filed 1.4y ago· Jan 8, 2025
29 days to discloseLloyd Doggett
DHouseTexas-37
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+51.9% vs S&P 500
Trade dateDec 10, 2024
⚑ Pharmaceutical
Filed 1.4y ago· Jan 6, 2025
31 days to disclose
Virginia Foxx
RHouseNorth Carolina-05
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+52.0% vs S&P 500
Trade dateDec 6, 2024
⚑ Pharmaceutical
Filed 1.4y ago· Dec 27, 2024
3 days to discloseMarjorie Taylor Greene
RHouseGeorgia-14
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+52.0% vs S&P 500
Trade dateDec 24, 2024
Filed 1.5y ago· Dec 9, 2024
31 days to discloseJared Moskowitz
DHouseFlorida-23
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+49.9% vs S&P 500
Trade dateNov 8, 2024
Filed 1.5y ago· Dec 5, 2024
9 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+47.2% vs S&P 500
Trade dateNov 26, 2024
Filed 1.5y ago· Dec 5, 2024
13 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+46.1% vs S&P 500
Trade dateNov 22, 2024
Filed 1.5y ago· Nov 27, 2024
2 days to discloseMarjorie Taylor Greene
RHouseGeorgia-14
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+46.3% vs S&P 500
Trade dateNov 25, 2024
Filed 1.6y ago· Oct 10, 2024
30 days to discloseLloyd Doggett
DHouseTexas-37
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+42.8% vs S&P 500
Trade dateSep 10, 2024
⚑ Pharmaceutical
Filed 1.7y ago· Sep 6, 2024
2 days to disclose
John James
RHouseMichigan-10
↓sold
Johnson & Johnson
JNJ
$1K-$15K
−5.2% vs S&P 500
Trade dateSep 4, 2024
⚑ Pharmaceutical
Filed 1.8y ago· Sep 2, 2024
297 days to disclose · 252 past 45-day windowJohn James
RHouseMichigan-10
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+39.5% vs S&P 500
Trade dateNov 10, 2023
⚑ Pharmaceutical
Filed 1.8y ago· Aug 21, 2024
202 days to disclose · 157 past 45-day windowJared Moskowitz
DHouseFlorida-23
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+4.4% vs S&P 500
Trade dateFeb 1, 2024
Filed 1.8y ago· Aug 20, 2024
13 days to discloseScott Franklin
RHouseFlorida-18
↑bought
Johnson & Johnson
JNJ
$15K-$50K
+43.9% vs S&P 500
Trade dateAug 7, 2024
Filed 1.8y ago· Aug 20, 2024
18 days to discloseScott Franklin
RHouseFlorida-18
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+47.1% vs S&P 500
Trade dateAug 2, 2024
Filed 1.8y ago· Aug 16, 2024
45 days to disclose
Kathy Manning
DHouseNorth Carolina-06
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+55.6% vs S&P 500
Trade dateJul 2, 2024
Filed 1.8y ago· Aug 16, 2024
45 days to discloseKathy Manning
DHouseNorth Carolina-06
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+55.6% vs S&P 500
Trade dateJul 2, 2024
Filed 1.8y ago· Aug 8, 2024
23 days to disclose
Rick W. Allen
RHouseGeorgia-12
↓sold
Johnson & Johnson
JNJ
$15K-$50K
−24.3% vs S&P 500
Trade dateJul 16, 2024
⚑ Pharmaceutical
Filed 1.8y ago· Aug 6, 2024
36 days to discloseJared Moskowitz
DHouseFlorida-23
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+55.5% vs S&P 500
Trade dateJul 1, 2024
Filed 1.9y ago· Jul 15, 2024
41 days to discloseKevin Hern
RHouseOklahoma-01
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+18.8% vs S&P 500
Trade dateJun 4, 2024
⚑ Pharmaceutical
Filed 1.9y ago· Jul 10, 2024
27 days to discloseRick W. Allen
RHouseGeorgia-12
↓sold
Johnson & Johnson
JNJ
$15K-$50K
−24.8% vs S&P 500
Trade dateJun 13, 2024
⚑ Pharmaceutical
Filed 1.9y ago· Jul 9, 2024
18 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+1.2% vs S&P 500
Trade dateJun 21, 2024
Filed 1.9y ago· Jul 3, 2024
29 days to discloseLloyd Doggett
DHouseTexas-37
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+18.8% vs S&P 500
Trade dateJun 4, 2024
⚑ Pharmaceutical
Filed 2.1y ago· Apr 12, 2024
38 days to discloseKevin Hern
RHouseOklahoma-01
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+1.4% vs S&P 500
Trade dateMar 5, 2024
⚑ Pharmaceutical
Filed 2.2y ago· Apr 9, 2024
35 days to discloseLloyd Doggett
DHouseTexas-37
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+1.4% vs S&P 500
Trade dateMar 5, 2024
⚑ Pharmaceutical
Filed 2.3y ago· Feb 6, 2024
14 days to discloseKathy Manning
DHouseNorth Carolina-06
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+6.1% vs S&P 500
Trade dateJan 23, 2024
Filed 2.4y ago· Jan 24, 2024
5 days to disclose
Blake D. Moore
RHouseUtah-01
↓sold
Johnson & Johnson
JNJ
$15K-$30K
+6.5% vs S&P 500
Trade dateJan 19, 2024
⚑ Pharmaceutical
Filed 2.4y ago· Jan 24, 2024
5 days to discloseBlake D. Moore
RHouseUtah-01
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+6.5% vs S&P 500
Trade dateJan 19, 2024
⚑ Pharmaceutical
Filed 2.4y ago· Jan 8, 2024
27 days to discloseLloyd Doggett
DHouseTexas-37
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+37.2% vs S&P 500
Trade dateDec 12, 2023
⚑ Pharmaceutical
Filed 2.6y ago· Oct 13, 2023
24 days to discloseKevin Hern
RHouseOklahoma-01
↑bought
Johnson & Johnson
JNJ
$1K-$15K
−21.0% vs S&P 500
Trade dateSep 19, 2023
⚑ Pharmaceutical
Filed 2.6y ago· Oct 12, 2023
31 days to discloseScott Franklin
RHouseFlorida-18
↓sold
Johnson & Johnson
JNJ
$15K-$50K
+11.7% vs S&P 500
Trade dateSep 11, 2023
Filed 2.6y ago· Oct 10, 2023
34 days to disclose
Lois Frankel
DHouseFlorida-22
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+13.0% vs S&P 500
Trade dateSep 6, 2023
Filed 2.7y ago· Oct 5, 2023
23 days to discloseLloyd Doggett
DHouseTexas-37
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+29.6% vs S&P 500
Trade dateSep 12, 2023
⚑ Pharmaceutical
Filed 2.8y ago· Aug 26, 2023
16 days to discloseLois Frankel
DHouseFlorida-22
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+24.2% vs S&P 500
Trade dateAug 10, 2023
Filed 2.8y ago· Aug 23, 2023
16 days to disclose
Michael Guest
RHouseMississippi-03
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+22.8% vs S&P 500
Trade dateAug 7, 2023
Filed 2.8y ago· Aug 13, 2023
34 days to disclose
Daniel S. Goldman
DHouseNew York-10
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+14.2% vs S&P 500
Trade dateJul 10, 2023
Filed 2.8y ago· Aug 10, 2023
828 days to disclose · 783 past 45-day windowRick W. Allen
RHouseGeorgia-12
↑bought
Johnson & Johnson
JNJ
$15K-$50K
−36.2% vs S&P 500
Trade dateMay 4, 2021
⚑ Pharmaceutical
Filed 2.9y ago· Jul 12, 2023
26 days to discloseKevin Hern
RHouseOklahoma-01
↑bought
Johnson & Johnson
JNJ
$1K-$15K
−24.8% vs S&P 500
Trade dateJun 16, 2023
⚑ Pharmaceutical
Filed 2.9y ago· Jul 10, 2023
27 days to discloseLloyd Doggett
DHouseTexas-37
↑bought
Johnson & Johnson
JNJ
$1K-$15K
−22.0% vs S&P 500
Trade dateJun 13, 2023
⚑ Pharmaceutical
Filed 3.2y ago· Apr 10, 2023
13 days to discloseKevin Hern
RHouseOklahoma-01
↑bought
Johnson & Johnson
JNJ
$1K-$15K
−30.6% vs S&P 500
Trade dateMar 28, 2023
⚑ Pharmaceutical
Filed 3.2y ago· Apr 10, 2023
28 days to discloseLloyd Doggett
DHouseTexas-37
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+31.8% vs S&P 500
Trade dateMar 13, 2023
⚑ Pharmaceutical
Filed 3.2y ago· Mar 20, 2023
21 days to discloseDaniel S. Goldman
DHouseNew York-10
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+32.7% vs S&P 500
Trade dateFeb 27, 2023
Filed 3.2y ago· Mar 13, 2023
24 days to discloseLois Frankel
DHouseFlorida-22
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+33.9% vs S&P 500
Trade dateFeb 17, 2023
Filed 3.2y ago· Mar 11, 2023
15 days to discloseThomas H. Kean Jr.
RHouseNew Jersey-07
↓sold
Johnson & Johnson
JNJ
$15K-$50K
+15.6% vs S&P 500
Trade dateFeb 24, 2023
⚑ Pharmaceutical
Filed 3.3y ago· Feb 17, 2023
37 days to discloseJosh Gottheimer
DHouseNew Jersey-05
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+9.8% vs S&P 500
Trade dateJan 11, 2023
Filed 3.3y ago· Feb 14, 2023
14 days to discloseKevin Hern
RHouseOklahoma-01
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+36.4% vs S&P 500
Trade dateJan 31, 2023
⚑ Pharmaceutical
Filed 3.3y ago· Feb 11, 2023
32 days to discloseThomas H. Kean Jr.
RHouseNew Jersey-07
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+10.4% vs S&P 500
Trade dateJan 10, 2023
⚑ Pharmaceutical
Filed 3.4y ago· Jan 5, 2023
23 days to discloseLloyd Doggett
DHouseTexas-37
↑bought
Johnson & Johnson
JNJ
$1K-$15K
−50.7% vs S&P 500
Trade dateDec 13, 2022
⚑ Pharmaceutical
| Filed | Politician | Type | Stock | Trade date | Smart move? | Size |
|---|---|---|---|---|---|---|
Apr 13, 2026 1mo ago | Thomas H. Kean Jr. RHouseNew Jersey-07 | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Energy and Commerce | Mar 26, 2026 18 days to disclose | Flat·+0.0% +1.9% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 7, 2026 1mo ago | Richard McCormick RHouseGeorgia-07 | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Investigations and Oversight | Mar 19, 2026 19 days to disclose | Flat·+0.0% +1.3% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 7, 2026 1mo ago | Richard McCormick RHouseGeorgia-07 | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Investigations and Oversight | Mar 19, 2026 19 days to disclose | Flat·+0.0% +1.3% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 6, 2026 1mo ago | Lloyd Doggett DHouseTexas-37 | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Ways and Means | Mar 10, 2026 27 days to disclose | Bad buy·−$407-5.1% −2.1% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 19, 2026 3mo ago | Thomas H. Kean Jr. RHouseNew Jersey-07 | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Energy and Commerce | Jan 23, 2026 27 days to disclose | Flat·+0.0% −5.7% vs S&P 500 | $15K-$50K midpoint $32.5K |
Jan 15, 2026 4mo ago | Julie Johnson DHouseTexas-32 | ↓sold | Johnson & Johnson JNJ | Dec 18, 2025 28 days to disclose | Flat·+0.0% −3.5% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 2, 2026 5mo ago | Lloyd Doggett DHouseTexas-37 | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Ways and Means | Dec 9, 2025 24 days to disclose | Good buy·+$1.3K+15.7% +16.6% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 19, 2025 5mo ago | Thomas H. Kean Jr. RHouseNew Jersey-07 | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Energy and Commerce | Nov 20, 2025 29 days to disclose | Flat·+0.0% −1.9% vs S&P 500 | $15K-$50K midpoint $32.5K |
Dec 11, 2025 5mo ago | Julie Johnson DHouseTexas-32 | ↓sold | Johnson & Johnson JNJ | Nov 13, 2025 28 days to disclose | Flat·+0.0% −2.8% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 9, 2025 5mo ago | Richard McCormick RHouseGeorgia-07 | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Investigations and Oversight | Nov 5, 2025 34 days to disclose | Good buy·+$1.9K+24.4% +22.4% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 22, 2025 6mo ago | Jared Moskowitz DHouseFlorida-23 | ↓sold | Johnson & Johnson JNJ | Oct 10, 2025 43 days to disclose | Flat·+0.0% +4.5% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 22, 2025 6mo ago | Jared Moskowitz DHouseFlorida-23 | ↓sold | Johnson & Johnson JNJ | Oct 10, 2025 43 days to disclose | Flat·+0.0% +4.5% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 21, 2025 6mo ago | Lisa C. McClain RHouseMichigan-09 | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Oct 31, 2025 21 days to disclose | Flat·+0.0% +3.0% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 21, 2025 6mo ago | Lisa C. McClain RHouseMichigan-09 | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Oct 30, 2025 22 days to disclose | Flat·+0.0% +2.9% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 21, 2025 6mo ago | Lisa C. McClain RHouseMichigan-09 | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Oct 30, 2025 22 days to disclose | Good buy·+$1.8K+22.4% +19.4% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 10, 2025 7mo ago | Val T. Hoyle DHouseOregon-04 | ↓sold | Johnson & Johnson JNJ | Sep 23, 2025 17 days to disclose | Flat·+0.0% +8.4% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 5, 2025 8mo ago | Sheri Biggs RHouseSouth Carolina-03 | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Research and Technology | Mar 19, 2025 200 days to disclose · 155 past 45-day window | Flat·+0.0% +1.1% vs S&P 500 | $15K-$50K midpoint $32.5K |
Sep 17, 2025 8mo ago | Richard McCormick RHouseGeorgia-07 | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Investigations and Oversight | Mar 15, 2023 917 days to disclose · 872 past 45-day window | Good buy·+$4K+49.9% +32.3% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | Lisa C. McClain RHouseMichigan-09 | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Aug 4, 2025 39 days to disclose | Good buy·+$2.8K+35.2% +23.6% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | Val T. Hoyle DHouseOregon-04 | ↑bought | Johnson & Johnson JNJ | Oct 29, 2024 318 days to disclose · 273 past 45-day window | Good buy·+$3.8K+47.6% +47.5% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 11, 2025 8mo ago | Kelly Morrison DHouseMinnesota-03 | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Health | Aug 19, 2025 23 days to disclose | Flat·+0.0% +8.6% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 11, 2025 8mo ago | Julie Johnson DHouseTexas-32 | ↓sold | Johnson & Johnson JNJ | Aug 14, 2025 28 days to disclose | Flat·+0.0% +10.9% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 20, 2025 9mo ago | Thomas H. Kean Jr. RHouseNew Jersey-07 | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Energy and Commerce | Jul 31, 2025 20 days to disclose | Flat·+0.0% +13.9% vs S&P 500 | $15K-$50K midpoint $32.5K |
Aug 20, 2025 9mo ago | Ritchie Torres DHouseNew York-15 | ↑bought | Johnson & Johnson JNJ | Sep 26, 2024 328 days to disclose · 283 past 45-day window | Good buy·+$3.3K+41.0% +16.2% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 13, 2025 9mo ago | Lisa C. McClain RHouseMichigan-09 | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Jun 24, 2025 50 days to disclose · 5 past 45-day window | Flat·+0.0% +11.0% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 13, 2025 9mo ago | Lisa C. McClain RHouseMichigan-09 | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Jun 17, 2025 57 days to disclose · 12 past 45-day window | Good buy·+$4.1K+51.8% +40.5% vs S&P 500 | $1K-$15K midpoint $8K |
Jul 14, 2025 10mo ago | Scott Franklin RHouseFlorida-18 | ↓sold | Johnson & Johnson JNJ | Jun 16, 2025 28 days to disclose | Flat·+0.0% +9.4% vs S&P 500 | $15K-$50K midpoint $32.5K |
Jul 7, 2025 11mo ago | Lloyd Doggett DHouseTexas-37 | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Ways and Means | Jun 10, 2025 27 days to disclose | Good buy·+$3.8K+47.8% +38.4% vs S&P 500 | $1K-$15K midpoint $8K |
Jul 3, 2025 11mo ago | Scott Franklin RHouseFlorida-18 | ↑bought | Johnson & Johnson JNJ | Aug 7, 2024 330 days to disclose · 285 past 45-day window | Good buy·+$3.6K+45.6% +43.9% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 22, 2025 11mo ago | Jefferson Shreve RHouseIndiana-06 | ↓sold | Johnson & Johnson JNJ | May 12, 2025 41 days to disclose | Flat·+0.0% +9.2% vs S&P 500 | $50K-$100K midpoint $75K |
Jun 21, 2025 11mo ago | Pete Sessions RHouseTexas-17 | ↓sold | Johnson & Johnson JNJ | Jun 12, 2025 9 days to disclose | Flat·+0.0% +8.6% vs S&P 500 | $15K-$50K midpoint $32.5K |
Jun 6, 2025 12mo ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Johnson & Johnson JNJ | May 30, 2025 7 days to disclose | Good buy·+$15.9K+49.0% +37.1% vs S&P 500 | $15K-$50K midpoint $32.5K |
May 14, 2025 1.1y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Johnson & Johnson JNJ | Apr 9, 2025 35 days to disclose | Flat·+0.0% +7.0% vs S&P 500 | $1K-$15K midpoint $8K |
May 14, 2025 1.1y ago | Julie Johnson DHouseTexas-32 | ↓sold | Johnson & Johnson JNJ | Apr 1, 2025 43 days to disclose | Flat·+0.0% +3.6% vs S&P 500 | $1K-$15K midpoint $8K |
May 12, 2025 1.1y ago | Bruce Westerman RHouseArkansas-04 | ↓sold | Johnson & Johnson JNJ | Apr 21, 2025 21 days to disclose | Flat·+0.0% +12.0% vs S&P 500 | $1K-$15K midpoint $8K |
May 6, 2025 1.1y ago | Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Johnson & Johnson JNJ | May 5, 2025 1 day to disclose | Good buy·+$3.9K+49.2% +41.7% vs S&P 500 | $1K-$15K midpoint $8K |
May 6, 2025 1.1y ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↓sold | Johnson & Johnson JNJ | Apr 29, 2025 7 days to disclose | Flat·+0.0% +6.6% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 28, 2025 1.1y ago | Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Conservation, Research, and Biotechnology | Apr 8, 2025 20 days to disclose | Flat·+0.0% +11.7% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 23, 2025 1.1y ago | George Whitesides DHouseCalifornia-27 | ↓sold | Johnson & Johnson JNJ | Mar 24, 2025 30 days to disclose | Flat·+0.0% +2.2% vs S&P 500 | $100K-$250K midpoint $175K |
Apr 16, 2025 1.1y ago | Bruce Westerman RHouseArkansas-04 | ↑bought | Johnson & Johnson JNJ | Mar 3, 2025 44 days to disclose | Good buy·+$3.1K+38.3% +39.0% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 11, 2025 1.1y ago | Jefferson Shreve RHouseIndiana-06 | ↑bought | Johnson & Johnson JNJ | Mar 5, 2025 37 days to disclose | Good buy·+$13K+40.1% +40.9% vs S&P 500 | $15K-$50K midpoint $32.5K |
Apr 10, 2025 1.1y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Johnson & Johnson JNJ | Mar 7, 2025 34 days to disclose | Flat·+0.0% −0.5% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 7, 2025 1.2y ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Johnson & Johnson JNJ | Mar 31, 2025 7 days to disclose | Good buy·+$12.8K+39.5% +37.8% vs S&P 500 | $15K-$50K midpoint $32.5K |
Apr 7, 2025 1.2y ago | Lloyd Doggett DHouseTexas-37 | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Ways and Means | Mar 4, 2025 34 days to disclose | Good buy·+$3.2K+39.8% +39.6% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 9, 2025 1.2y ago | Jefferson Shreve RHouseIndiana-06 | ↑bought | Johnson & Johnson JNJ | Feb 24, 2025 13 days to disclose | Good buy·+$13.4K+41.3% +40.7% vs S&P 500 | $15K-$50K midpoint $32.5K |
Feb 11, 2025 1.3y ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↓sold | Johnson & Johnson JNJ | Jan 24, 2025 18 days to disclose | Flat·+0.0% +2.9% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 10, 2025 1.3y ago | Josh Gottheimer DHouseNew Jersey-05 | ↑bought | Johnson & Johnson JNJ | Jan 24, 2025 17 days to disclose | Good buy·+$4.6K+57.5% +54.6% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 10, 2025 1.3y ago | Josh Gottheimer DHouseNew Jersey-05 | ↑bought | Johnson & Johnson JNJ | Jan 21, 2025 20 days to disclose | Good buy·+$4.5K+56.1% +51.9% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 10, 2025 1.3y ago | Josh Gottheimer DHouseNew Jersey-05 | ↑bought | Johnson & Johnson JNJ | Jan 16, 2025 25 days to disclose | Good buy·+$4.5K+56.5% +51.3% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 27, 2025 1.3y ago | Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Johnson & Johnson JNJ | Jan 8, 2025 19 days to disclose | Good buy·+$5K+62.6% +56.8% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 27, 2025 1.3y ago | Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Johnson & Johnson JNJ | Jan 8, 2025 19 days to disclose | Good buy·+$5K+62.6% +56.8% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 27, 2025 1.3y ago | Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Johnson & Johnson JNJ | Jan 8, 2025 19 days to disclose | Good buy·+$5K+62.6% +56.8% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 15, 2025 1.4y ago | Kevin Hern RHouseOklahoma-01 | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Ways and Means | Dec 31, 2024 15 days to disclose | Flat·+0.0% +8.0% vs S&P 500 | $100K-$250K midpoint $175K |
Jan 14, 2025 1.4y ago | Josh Gottheimer DHouseNew Jersey-05 | ↑bought | Johnson & Johnson JNJ | Dec 12, 2024 33 days to disclose | Good buy·+$4.7K+58.2% +52.9% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 8, 2025 1.4y ago | Lloyd Doggett DHouseTexas-37 | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Ways and Means | Dec 10, 2024 29 days to disclose | Good buy·+$4.4K+55.0% +51.9% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 6, 2025 1.4y ago | Virginia Foxx RHouseNorth Carolina-05 | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Dec 6, 2024 31 days to disclose | Good buy·+$4.4K+54.9% +52.0% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 27, 2024 1.4y ago | Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Johnson & Johnson JNJ | Dec 24, 2024 3 days to disclose | Good buy·+$4.7K+58.6% +52.0% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 9, 2024 1.5y ago | Jared Moskowitz DHouseFlorida-23 | ↑bought | Johnson & Johnson JNJ | Nov 8, 2024 31 days to disclose | Good buy·+$3.9K+48.8% +49.9% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 5, 2024 1.5y ago | Josh Gottheimer DHouseNew Jersey-05 | ↑bought | Johnson & Johnson JNJ | Nov 26, 2024 9 days to disclose | Good buy·+$3.9K+48.8% +47.2% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 5, 2024 1.5y ago | Josh Gottheimer DHouseNew Jersey-05 | ↑bought | Johnson & Johnson JNJ | Nov 22, 2024 13 days to disclose | Good buy·+$3.9K+49.1% +46.1% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 27, 2024 1.5y ago | Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Johnson & Johnson JNJ | Nov 25, 2024 2 days to disclose | Good buy·+$3.9K+48.5% +46.3% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 10, 2024 1.6y ago | Lloyd Doggett DHouseTexas-37 | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Ways and Means | Sep 10, 2024 30 days to disclose | Good buy·+$3.1K+38.2% +42.8% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 6, 2024 1.7y ago | John James RHouseMichigan-10 | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Energy and Commerce | Sep 4, 2024 2 days to disclose | Flat·+0.0% −5.2% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 2, 2024 1.8y ago | John James RHouseMichigan-10 | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Energy and Commerce | Nov 10, 2023 297 days to disclose · 252 past 45-day window | Good buy·+$4.6K+57.1% +39.5% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 21, 2024 1.8y ago | Jared Moskowitz DHouseFlorida-23 | ↓sold | Johnson & Johnson JNJ | Feb 1, 2024 202 days to disclose · 157 past 45-day window | Flat·+0.0% +4.4% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 20, 2024 1.8y ago | Scott Franklin RHouseFlorida-18 | ↑bought | Johnson & Johnson JNJ | Aug 7, 2024 13 days to disclose | Good buy·+$14.8K+45.6% +43.9% vs S&P 500 | $15K-$50K midpoint $32.5K |
Aug 20, 2024 1.8y ago | Scott Franklin RHouseFlorida-18 | ↑bought | Johnson & Johnson JNJ | Aug 2, 2024 18 days to disclose | Good buy·+$3.6K+45.5% +47.1% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 16, 2024 1.8y ago | Kathy Manning DHouseNorth Carolina-06 | ↑bought | Johnson & Johnson JNJ | Jul 2, 2024 45 days to disclose | Good buy·+$4.7K+58.4% +55.6% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 16, 2024 1.8y ago | Kathy Manning DHouseNorth Carolina-06 | ↑bought | Johnson & Johnson JNJ | Jul 2, 2024 45 days to disclose | Good buy·+$4.7K+58.4% +55.6% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 8, 2024 1.8y ago | Rick W. Allen RHouseGeorgia-12 | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Jul 16, 2024 23 days to disclose | Missed gain·−$16.5K-50.7% −24.3% vs S&P 500 | $15K-$50K midpoint $32.5K |
Aug 6, 2024 1.8y ago | Jared Moskowitz DHouseFlorida-23 | ↑bought | Johnson & Johnson JNJ | Jul 1, 2024 36 days to disclose | Good buy·+$4.6K+58.0% +55.5% vs S&P 500 | $1K-$15K midpoint $8K |
Jul 15, 2024 1.9y ago | Kevin Hern RHouseOklahoma-01 | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Ways and Means | Jun 4, 2024 41 days to disclose | Good buy·+$4.3K+53.9% +18.8% vs S&P 500 | $1K-$15K midpoint $8K |
Jul 10, 2024 1.9y ago | Rick W. Allen RHouseGeorgia-12 | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Jun 13, 2024 27 days to disclose | Missed gain·−$18.3K-56.4% −24.8% vs S&P 500 | $15K-$50K midpoint $32.5K |
Jul 9, 2024 1.9y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Johnson & Johnson JNJ | Jun 21, 2024 18 days to disclose | Flat·+0.0% +1.2% vs S&P 500 | $1K-$15K midpoint $8K |
Jul 3, 2024 1.9y ago | Lloyd Doggett DHouseTexas-37 | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Ways and Means | Jun 4, 2024 29 days to disclose | Good buy·+$4.3K+53.9% +18.8% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 12, 2024 2.1y ago | Kevin Hern RHouseOklahoma-01 | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Ways and Means | Mar 5, 2024 38 days to disclose | Good buy·+$3.4K+42.2% +1.4% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 9, 2024 2.2y ago | Lloyd Doggett DHouseTexas-37 | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Ways and Means | Mar 5, 2024 35 days to disclose | Good buy·+$3.4K+42.2% +1.4% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 6, 2024 2.3y ago | Kathy Manning DHouseNorth Carolina-06 | ↓sold | Johnson & Johnson JNJ | Jan 23, 2024 14 days to disclose | Flat·+0.0% +6.1% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 24, 2024 2.4y ago | Blake D. Moore RHouseUtah-01 | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Ways and Means | Jan 19, 2024 5 days to disclose | Flat·+0.0% +6.5% vs S&P 500 | $15K-$30K midpoint $22.5K |
Jan 24, 2024 2.4y ago | Blake D. Moore RHouseUtah-01 | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Ways and Means | Jan 19, 2024 5 days to disclose | Flat·+0.0% +6.5% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 8, 2024 2.4y ago | Lloyd Doggett DHouseTexas-37 | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Ways and Means | Dec 12, 2023 27 days to disclose | Good buy·+$3.9K+48.5% +37.2% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 13, 2023 2.6y ago | Kevin Hern RHouseOklahoma-01 | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Ways and Means | Sep 19, 2023 24 days to disclose | Good buy·+$3.2K+40.3% −21.0% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 12, 2023 2.6y ago | Scott Franklin RHouseFlorida-18 | ↓sold | Johnson & Johnson JNJ | Sep 11, 2023 31 days to disclose | Flat·+0.0% +11.7% vs S&P 500 | $15K-$50K midpoint $32.5K |
Oct 10, 2023 2.6y ago | Lois Frankel DHouseFlorida-22 | ↓sold | Johnson & Johnson JNJ | Sep 6, 2023 34 days to disclose | Flat·+0.0% +13.0% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 5, 2023 2.7y ago | Lloyd Doggett DHouseTexas-37 | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Ways and Means | Sep 12, 2023 23 days to disclose | Good buy·+$3.3K+41.4% +29.6% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 26, 2023 2.8y ago | Lois Frankel DHouseFlorida-22 | ↑bought | Johnson & Johnson JNJ | Aug 10, 2023 16 days to disclose | Good buy·+$2.7K+34.3% +24.2% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 23, 2023 2.8y ago | Michael Guest RHouseMississippi-03 | ↑bought | Johnson & Johnson JNJ | Aug 7, 2023 16 days to disclose | Good buy·+$2.7K+33.7% +22.8% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 13, 2023 2.8y ago | Daniel S. Goldman DHouseNew York-10 | ↓sold | Johnson & Johnson JNJ | Jul 10, 2023 34 days to disclose | Flat·+0.0% +14.2% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 10, 2023 2.8y ago | Rick W. Allen RHouseGeorgia-12 | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | May 4, 2021 828 days to disclose · 783 past 45-day window | Good buy·+$11.6K+35.6% −36.2% vs S&P 500 | $15K-$50K midpoint $32.5K |
Jul 12, 2023 2.9y ago | Kevin Hern RHouseOklahoma-01 | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Ways and Means | Jun 16, 2023 26 days to disclose | Good buy·+$3.1K+38.5% −24.8% vs S&P 500 | $1K-$15K midpoint $8K |
Jul 10, 2023 2.9y ago | Lloyd Doggett DHouseTexas-37 | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Ways and Means | Jun 13, 2023 27 days to disclose | Good buy·+$3.3K+41.5% −22.0% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 10, 2023 3.2y ago | Kevin Hern RHouseOklahoma-01 | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Ways and Means | Mar 28, 2023 13 days to disclose | Good buy·+$4K+49.8% −30.6% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 10, 2023 3.2y ago | Lloyd Doggett DHouseTexas-37 | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Ways and Means | Mar 13, 2023 28 days to disclose | Good buy·+$4K+50.3% +31.8% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 20, 2023 3.2y ago | Daniel S. Goldman DHouseNew York-10 | ↑bought | Johnson & Johnson JNJ | Feb 27, 2023 21 days to disclose | Good buy·+$3.9K+48.6% +32.7% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 13, 2023 3.2y ago | Lois Frankel DHouseFlorida-22 | ↑bought | Johnson & Johnson JNJ | Feb 17, 2023 24 days to disclose | Good buy·+$3.7K+46.4% +33.9% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 11, 2023 3.2y ago | Thomas H. Kean Jr. RHouseNew Jersey-07 | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Energy and Commerce | Feb 24, 2023 15 days to disclose | Flat·+0.0% +15.6% vs S&P 500 | $15K-$50K midpoint $32.5K |
Feb 17, 2023 3.3y ago | Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Johnson & Johnson JNJ | Jan 11, 2023 37 days to disclose | Flat·+0.0% +9.8% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 14, 2023 3.3y ago | Kevin Hern RHouseOklahoma-01 | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Ways and Means | Jan 31, 2023 14 days to disclose | Missed gain·−$3.1K-39.2% +36.4% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 11, 2023 3.3y ago | Thomas H. Kean Jr. RHouseNew Jersey-07 | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Energy and Commerce | Jan 10, 2023 32 days to disclose | Flat·+0.0% +10.4% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 5, 2023 3.4y ago | Lloyd Doggett DHouseTexas-37 | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Ways and Means | Dec 13, 2022 23 days to disclose | Good buy·+$2.2K+26.9% −50.7% vs S&P 500 | $1K-$15K midpoint $8K |